Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      • Home
      • Medical Dialogues...

      Articles By : Medical Dialogues Bureau

      Money laundering case: Sterling Biotechs director arrested sent to ED custody

      Money laundering case: Sterling Biotech's director arrested sent to ED custody

      Medical Dialogues Bureau27 Jan 2018 10:00 AM IST
      New Delhi: A Director of Gujarat-based pharma firm was Friday sent to the one-day custody of Enforcement Directorate, which arrested him last night in...
      Axio Biosolutions raises Rs 47 crore from Ratan Tata, others

      Axio Biosolutions raises Rs 47 crore from Ratan Tata, others

      Medical Dialogues Bureau27 Jan 2018 10:00 AM IST
      New Delhi: Ratan Tata-led firm RNT Capital along with Accel Partners and IDG Ventures India have invested USD 7.4 million (Rs 47 crore) in a medical...
      Abbott results beat on strong medical device business

      Abbott results beat on strong medical device business

      Medical Dialogues Bureau27 Jan 2018 9:45 AM IST
      Abbott Laboratories' fourth-quarter results topped analysts' estimates, boosted by strong sales in its medical devices and generics businesses.Shares...
      US appeals court upholds ruling invalidating Johnson and Johnson patent on Remicade

      US appeals court upholds ruling invalidating Johnson and Johnson patent on Remicade

      Medical Dialogues Bureau27 Jan 2018 9:30 AM IST
      A U.S. appeals court upheld a ruling that invalidated a crucial Johnson and Johnson patent on its blockbuster rheumatoid arthritis drug Remicade,...
      WHO grants prequalification to Bharat Biotechs rotavirus vaccine, ROTAVAC

      WHO grants prequalification to Bharat Biotech's rotavirus vaccine, ROTAVAC

      Medical Dialogues Bureau26 Jan 2018 10:44 AM IST
      Bharat Biotech announced that the World Health Organization (WHO Geneva) has awarded prequalification to the developing world’s first rotavirus...
      US generic business to face pricing pressure for 12 months: ICRA

      US generic business to face pricing pressure for 12 months: ICRA

      Medical Dialogues Bureau26 Jan 2018 10:30 AM IST
      MUMBAI: Domestic pharma companies are expected to face pricing pressure by 10-12 percent on US generic business which may sustain for the next 12...
      Novartis says Entresto could become 5 billion dollars a year blockbuster drug

      Novartis says Entresto could become 5 billion dollars a year blockbuster drug

      Medical Dialogues Bureau26 Jan 2018 10:00 AM IST
      A Novartis executive said the Swiss company’s heart failure medicine Entries to could be used more widely in future, potentially making it a...
      Spark licenses blindness gene therapy rights outside US to Novartis

      Spark licenses blindness gene therapy rights outside US to Novartis

      Medical Dialogues Bureau26 Jan 2018 9:45 AM IST
      Spark Therapeutics Inc, whose breakthrough gene therapy to treat a rare form of blindness was approved by U.S. regulators in December, said on...
      Philip Morris sees six million US smokers switching to iQOS device if cleared

      Philip Morris sees six million US smokers switching to iQOS device if cleared

      Medical Dialogues Bureau26 Jan 2018 9:30 AM IST
      Philip Morris International Inc told a U.S. advisory panel on Wednesday that it expects around 6 million smokers to switch completely to its iQOS...
      NATHEALTH expresses anguish at receding govt attention on healthcare

      NATHEALTH expresses anguish at receding govt attention on healthcare

      Medical Dialogues Bureau25 Jan 2018 12:51 PM IST
      New Delhi: Supporting the government's measures and reforms for the healthcare sector, Healthcare Federation of India - NATHEALTH has expressed...
      Pfizer Q3 net profit up 40 percent at Rs 87 crore

      Pfizer Q3 net profit up 40 percent at Rs 87 crore

      Medical Dialogues Bureau25 Jan 2018 11:00 AM IST
      New Delhi: Drug firm Pfizer reported a 39.87 percent rise in its net profit at Rs 87.24 crore for the quarter ended December 2017, mainly on account...
      ICICI Lombard launches solution to transform OPD health Insurance

      ICICI Lombard launches solution to transform OPD health Insurance

      Medical Dialogues Bureau25 Jan 2018 10:00 AM IST
      New Delhi: ICICI Lombard General Insurance, one of the leading general insurance companies in the country has launched a health insurance app — ‘IL...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok